These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34986538)

  • 1. Progress on the application of positron emission tomography imaging of cannabinoid type 1 receptor in neuropsychiatric diseases.
    Ma L; Wu S; Zhang K; Tian M; Zhang H
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Oct; 50(5):666-673. PubMed ID: 34986538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET imaging of synaptic density: A new tool for investigation of neuropsychiatric diseases.
    Cai Z; Li S; Matuskey D; Nabulsi N; Huang Y
    Neurosci Lett; 2019 Jan; 691():44-50. PubMed ID: 30075287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endocannabinoidome in neuropsychiatry: Opportunities and potential risks.
    Morris G; Walder K; Kloiber S; Amminger P; Berk M; Bortolasci CC; Maes M; Puri BK; Carvalho AF
    Pharmacol Res; 2021 Aug; 170():105729. PubMed ID: 34119623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of positron emission tomography in animal models of neurological and neuropsychiatric disorders.
    Virdee K; Cumming P; Caprioli D; Jupp B; Rominger A; Aigbirhio FI; Fryer TD; Riss PJ; Dalley JW
    Neurosci Biobehav Rev; 2012 Apr; 36(4):1188-216. PubMed ID: 22342372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders.
    Kibret BG; Ishiguro H; Horiuchi Y; Onaivi ES
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of BiP as a CB
    Costas-Insua C; Moreno E; Maroto IB; Ruiz-Calvo A; Bajo-Grañeras R; Martín-Gutiérrez D; Diez-Alarcia R; Vilaró MT; Cortés R; García-Font N; Martín R; Espina M; Botta J; Ginés S; McCormick PJ; Sánchez-Prieto J; Galve-Roperh I; Mengod G; Urigüen L; Marsicano G; Bellocchio L; Canela EI; Casadó V; Rodríguez-Crespo I; Guzmán M
    J Neurosci; 2021 Sep; 41(38):7924-7941. PubMed ID: 34353897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [
    Takkinen JS; López-Picón FR; Kirjavainen AK; Pihlaja R; Snellman A; Ishizu T; Löyttyniemi E; Solin O; Rinne JO; Haaparanta-Solin M
    Neurobiol Aging; 2018 Sep; 69():199-208. PubMed ID: 29909177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid receptor-interacting protein 1a modulates CB1 receptor signaling and regulation.
    Smith TH; Blume LC; Straiker A; Cox JO; David BG; McVoy JR; Sayers KW; Poklis JL; Abdullah RA; Egertová M; Chen CK; Mackie K; Elphick MR; Howlett AC; Selley DE
    Mol Pharmacol; 2015 Apr; 87(4):747-65. PubMed ID: 25657338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies.
    Sloan ME; Grant CW; Gowin JL; Ramchandani VA; Le Foll B
    Acta Pharmacol Sin; 2019 Mar; 40(3):342-350. PubMed ID: 30166624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional changes in the type 1 cannabinoid receptor are associated with cognitive dysfunction in Parkinson's disease.
    Ceccarini J; Casteels C; Ahmad R; Crabbé M; Van de Vliet L; Vanhaute H; Vandenbulcke M; Vandenberghe W; Van Laere K
    Eur J Nucl Med Mol Imaging; 2019 Oct; 46(11):2348-2357. PubMed ID: 31342135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of cannabinoid CB1 receptor and cholecystokinin immunoreactivity in monkey dorsolateral prefrontal cortex.
    Eggan SM; Melchitzky DS; Sesack SR; Fish KN; Lewis DA
    Neuroscience; 2010 Sep; 169(4):1651-61. PubMed ID: 20542094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal poly I:C age-dependently alters cannabinoid type 1 receptors in offspring: a longitudinal small animal PET study using [(18)F]MK-9470.
    Verdurand M; Dalton VS; Nguyen V; Grégoire MC; Zahra D; Wyatt N; Burgess L; Greguric I; Zavitsanou K
    Exp Neurol; 2014 Jul; 257():162-9. PubMed ID: 24825369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex difference in brain CB1 receptor availability in man.
    Laurikainen H; Tuominen L; Tikka M; Merisaari H; Armio RL; Sormunen E; Borgan F; Veronese M; Howes O; Haaparanta-Solin M; Solin O; Hietala J;
    Neuroimage; 2019 Jan; 184():834-842. PubMed ID: 30296558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid receptor-interacting protein Crip1a modulates CB1 receptor signaling in mouse hippocampus.
    Guggenhuber S; Alpar A; Chen R; Schmitz N; Wickert M; Mattheus T; Harasta AE; Purrio M; Kaiser N; Elphick MR; Monory K; Kilb W; Luhmann HJ; Harkany T; Lutz B; Klugmann M
    Brain Struct Funct; 2016 May; 221(4):2061-74. PubMed ID: 25772509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET Radioligands for imaging of the PDE10A in human: current status.
    Boscutti G; A Rabiner E; Plisson C
    Neurosci Lett; 2019 Jan; 691():11-17. PubMed ID: 30099081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reciprocal alterations in cortical cannabinoid receptor 1 binding relative to protein immunoreactivity and transcript levels in schizophrenia.
    Volk DW; Eggan SM; Horti AG; Wong DF; Lewis DA
    Schizophr Res; 2014 Oct; 159(1):124-9. PubMed ID: 25107849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocannabinoid system in neurodegenerative disorders.
    Basavarajappa BS; Shivakumar M; Joshi V; Subbanna S
    J Neurochem; 2017 Sep; 142(5):624-648. PubMed ID: 28608560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodegenerative movement disorders: the contribution of functional imaging.
    Piccini P
    Curr Opin Neurol; 2004 Aug; 17(4):459-66. PubMed ID: 15247543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography imaging of cerebral glucose metabolism and type 1 cannabinoid receptor availability during temporal lobe epileptogenesis in the amygdala kindling model in rhesus monkeys.
    Cleeren E; Casteels C; Goffin K; Koole M; Van Laere K; Janssen P; Van Paesschen W
    Epilepsia; 2018 May; 59(5):959-970. PubMed ID: 29663353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor.
    Burns HD; Van Laere K; Sanabria-Bohórquez S; Hamill TG; Bormans G; Eng WS; Gibson R; Ryan C; Connolly B; Patel S; Krause S; Vanko A; Van Hecken A; Dupont P; De Lepeleire I; Rothenberg P; Stoch SA; Cote J; Hagmann WK; Jewell JP; Lin LS; Liu P; Goulet MT; Gottesdiener K; Wagner JA; de Hoon J; Mortelmans L; Fong TM; Hargreaves RJ
    Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9800-5. PubMed ID: 17535893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.